Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diurisa vs. Furosemide in NYHA Class II Congestive Heart Failure
NCT01210365Phase 3Terminated
- Sponsor
- Eurofarma
- Start
- Jan 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of furosemide in heart failure (HF), sponsored by Eurofarma. Started Jan 2011; status: terminated.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01210365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210365.